# MUC1 (mucin-1)

Source: https://onco.cc/targets/muc1/  
OnCo record `muc1` (Target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

MUC1 is a protein found on cells that line organs. Different fragments expose different binding sites, so a positive test does not tell us what a treatment will recognise.

## Summary

MUC1 encodes a cell-surface-associated mucin with an extracellular repeat region and a membrane-associated portion containing a signalling tail. Whole-protein expression, a particular cleavage product and the epitope recognised by a binder are different measurements.

Mahanta and colleagues used MUC1* for membrane-anchored cleavage products while noting uncertainty about the precise cleavage sites. Their antibody recognised a membrane-proximal extracellular region rather than the long tandem repeats. The study also found MUC1* staining on the luminal surface of noncancerous fallopian-tube epithelium. Neither generic MUC1 RNA nor a different antibody stain proves that the proposed receptor recognises the intended fragment or spares healthy tissue.

## Fields

- Kind: Target
- Last checked: 2026-11-12
- Also known as: Mucin-1; Mucin 1; CD227
- Symbol: MUC1
- Class: surface-antigen
- Biology: The extracellular alpha subunit can support adhesion or oppose it, while the beta-subunit cytoplasmic region participates in signalling. Tissue location, cleavage and epitope exposure affect what an antibody or engineered receptor can recognise.

## Notes

- Specify the actual extracellular epitope, cleavage or glycosylation context, binder and tissue. In the 2008 study, antibodies against the tandem repeats and the membrane-associated cleavage product gave different staining patterns. That mechanistic and tissue work was not a CAR-T clinical trial or evidence that every MUC1-directed design is tumour-exclusive.

## Sources

- HGNC:7508, MUC1: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7508
- UniProt P15941, reviewed human mucin-1: https://www.uniprot.org/uniprotkb/P15941/entry
- Mahanta et al., 2008: MUC1 cleavage-product study: https://pubmed.ncbi.nlm.nih.gov/18446242/

## Connected records

- terms: [On-target, off-tumour toxicity and off-target cross-reactivity](https://onco.cc/terms/on-target-off-tumour-toxicity/), [Tumour-associated antigen (TAA)](https://onco.cc/terms/tumor-associated-antigen/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/)

---
JSON: https://onco.cc/api/v1/entities/muc1.json